Investing in marijuana seems to be the current trend as high returns have been noted across the board, however, Investors have, in the past year, been spoiled by incredibly high yields since the stock market’s bounce back after 2008. The three major U.S. indexes have tripled in value, with the NASDAQ Composite reaching almost four times what it was in 2009.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has patented and licenses a novel delivery system which infuses organically sourced hemp oil into the molecules of other substances.
Tecogen® Inc. (NASDAQ: TGEN), a clean energy company providing ultra-efficient, clean, natural gas-powered on-site power, heating and cooling equipment, is pleased to announce the sale of three of its Tecochill "STx Series" chillers to an indoor cannabis growing operation near Tampa, FL. This marks Tecogen's first sale into Florida's recently legalized medical marijuana business.
OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ("OWC" or the "Company"), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced the appointment of Dr. Stanley Hirsch as its active chairman of the board of directors.
The number of cannabis-related offences reported to police and the number of pot possession charges were down again last year.
Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF) today announced that it has strengthened its management team with the appointment of Bernard Fortier to the position of Chief Executive Officer, effective today, July 24, 2017.
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., has officially filed a record of its first line of non-industrial hemp-infused skin care products with the China Food and Drug Administration (CFDA).
InMed Pharmaceuticals, Inc. (OTCMKTS:IMLFF) has closed a research and development contract with ATERA SAS of France, a key tissue engineering entity specializing in the advancement of innovative human tissue models.
Aurora Cannabis Inc. (the "Company" or "Aurora") (TSXV: ACB) (OTCQX: ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) announced today that common shares of the Company will commence trading on Toronto Stock Exchange (the "TSX") effective Monday July 24 . Common shares will continue to trade under the symbol "ACB".
ATERA specializes in the advancement, validation, commercialization and manufacturing of advanced tissue models as cost-effective, high-quality, reliable and more conscientious alternatives for animal trials. Under the deal, ATERA will advance 3D human skin models of Epidermolysis Bullosa to assess the efficiency of INM-750 and probe the beneficial effects of topically put INM-750 at ultra-structural molecular and cellular levels.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced the start of laboratory work under its collaborative research project with the National Research Council of Canada (“NRC”).
Lotus Ventures Inc. (“Lotus” or the “Company”) (CSE:J) is pleased to announce a non-brokered private placement offering (the “Offering”), the start of facility construction, provide details on its streaming agreement with Cannabis Wheaton Income Corp. (“CBW”) and an update on the regulatory licensing process.
Puration, Inc. (USOTC: PURA) today announced the acquisition of a 25-greenhouse grow operation. PURA operates a U.S. Patented Cannabis Extraction process and sells its extracts for infusion into a variety of consumer products.
Aaron Keay, CEO of ABcann Global Corporation, speaks with Natasha Frakes about why the company waited two years from getting their license before going public.
